A study published in the Lancet last week investigated millions of U.S. medical records to determine whether semaglutide increased the risk of neurological and psychiatric conditions within the first year of use compared to 3 other common antidiabetic medications. Authors found no association between semaglutide and a higher risk of the 22 studied conditions (eg, psychosis; bipolar disorder; depression; anxiety; opioid and alcohol use disorder; etc.). In fact, patients on semaglutide showed lower rates of …
Read More
